These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37747548)

  • 21. Evolution of Non-alcoholic Fatty Liver Disease (NAFLD) Biomarkers in Response to Weight Loss 1 Year After Bariatric Surgery-a Post Hoc Analysis of the FibroTest Prospective Study.
    Codjia T; Rebibo L; François A; Lagnel C; Huet E; Bekri S; Pattou F; Régimbeau JM; Schwarz L
    Obes Surg; 2021 Aug; 31(8):3548-3556. PubMed ID: 33844174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetes.
    Lembo E; Russo MF; Verrastro O; Anello D; Angelini G; Iaconelli A; Guidone C; Stefanizzi G; Ciccoritti L; Greco F; Sessa L; Riccardi L; Pompili M; Raffaelli M; Vecchio FM; Bornstein SR; Mingrone G; Gastaldelli A; Capristo E
    Diabetes Metab; 2022 Sep; 48(5):101363. PubMed ID: 35760372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistence of severe liver fibrosis despite substantial weight loss with bariatric surgery.
    Pais R; Aron-Wisnewsky J; Bedossa P; Ponnaiah M; Oppert JM; Siksik JM; Genser L; Charlotte F; Thabut D; Clement K; Ratziu V
    Hepatology; 2022 Aug; 76(2):456-468. PubMed ID: 35076966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compare the Combined Diagnostic Accuracy of Transient Elastography and Visual Liver Score in Assessing Non-Alcoholic Fatty Liver Disease (NAFLD) and Compare it with Liver Biopsy in Morbidly Obese Patients Undergoing Bariatric Surgery: An Observational Study.
    Sharma D; Anand G; Meena S; Bhardwaj V
    Obes Surg; 2024 Apr; 34(4):1247-1256. PubMed ID: 38411879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis.
    Lassailly G; Caiazzo R; Ntandja-Wandji LC; Gnemmi V; Baud G; Verkindt H; Ningarhari M; Louvet A; Leteurtre E; Raverdy V; Dharancy S; Pattou F; Mathurin P
    Gastroenterology; 2020 Oct; 159(4):1290-1301.e5. PubMed ID: 32553765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term effect of bariatric surgery on resolution of nonalcoholic steatohepatitis (NASH): An external validation and application of a clinical NASH score.
    Tan CH; Al-Kalifah N; Ser KH; Lee YC; Chen JC; Lee WJ
    Surg Obes Relat Dis; 2018 Oct; 14(10):1600-1606. PubMed ID: 30077664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bariatric surgery and non-alcoholic fatty liver disease.
    Julià H; Benaiges D; Pedro-Botet J
    Med Clin (Barc); 2022 Jun; 158(11):550-555. PubMed ID: 35120767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel subtype of obesity influencing the outcomes of sleeve gastrectomy: Familial aggregation of obesity.
    Wang ZY; Qu YF; Yu TM; Liu ZL; Cheng YG; Zhong MW; Hu SY
    World J Gastroenterol; 2024 Apr; 30(13):1887-1898. PubMed ID: 38659480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-alcoholic Fatty Liver Disease in Morbidly Obese Individuals Undergoing Bariatric Surgery: Prevalence and Effect of the Pre-Bariatric Very Low Calorie Diet.
    Schwenger KJP; Fischer SE; Jackson TD; Okrainec A; Allard JP
    Obes Surg; 2018 Apr; 28(4):1109-1116. PubMed ID: 29098545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
    Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
    World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and predictors of non-alcoholic steatohepatitis in patients with morbid obesity.
    Meneses D; Olveira A; Corripio R; Méndez MDC; Romero M; Calvo-Viñuelas I; Herranz L; Vicent D; de-Cos-Blanco AI
    Endocrinol Diabetes Nutr (Engl Ed); 2022 Mar; 69(3):178-188. PubMed ID: 35396116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visual Liver Score to Stratify Non-Alcoholic Steatohepatitis Risk and Determine Selective Intraoperative Liver Biopsy in Obesity.
    Ooi GJ; Burton PR; Earnest A; Laurie C; Kemp WW; Nottle PD; McLean CA; Roberts SK; Brown WA
    Obes Surg; 2018 Feb; 28(2):427-436. PubMed ID: 28776153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis.
    Aminian A; Al-Kurd A; Wilson R; Bena J; Fayazzadeh H; Singh T; Albaugh VL; Shariff FU; Rodriguez NA; Jin J; Brethauer SA; Dasarathy S; Alkhouri N; Schauer PR; McCullough AJ; Nissen SE
    JAMA; 2021 Nov; 326(20):2031-2042. PubMed ID: 34762106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and outcome of non-alcoholic fatty liver disease in adolescents and young adults undergoing weight loss surgery.
    Corey KE; Stanley TL; Misdraji J; Scirica C; Pratt J; Hoppin A; Misra M
    Pediatr Obes; 2014 Oct; 9(5):e91-3. PubMed ID: 24677740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Nonalcoholic Fatty Liver Disease (NAFLD) on Weight Loss After Bariatric Surgery.
    Abu-Rumaileh M; Haddad RA; Yosef M; Esfandiari NH; Kraftson A; Khairi S; Lager C; Bushman J; Khalatbari S; Tincopa M; Varban O; Bozadjieva-Kramer N; Oral EA
    Obes Surg; 2023 Dec; 33(12):3814-3828. PubMed ID: 37940737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Considerations for bariatric surgery in patients with cirrhosis.
    Goh GB; Schauer PR; McCullough AJ
    World J Gastroenterol; 2018 Jul; 24(28):3112-3119. PubMed ID: 30065557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are We Ready for Bariatric Surgery in a Liver Transplant Program? A Meta-Analysis.
    Lopez-Lopez V; Ruiz-Manzanera JJ; Eshmuminov D; Lehmann K; Schneider M; von der Groeben M; de Angulo DR; Gajownik U; Pons JA; Sánchez-Bueno F; Robles-Campos R; Ramírez-Romero P
    Obes Surg; 2021 Mar; 31(3):1214-1222. PubMed ID: 33225408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NASH Presence is Associated with a Lower Weight Loss One and 2 Years After Bariatric Surgery in Women with Severe Obesity.
    Sabench F; Bertran L; Vives M; París M; Aguilar C; Martínez S; Binetti J; Real M; Alibalic A; Richart C; Del Castillo D; Auguet T
    Obes Surg; 2022 Oct; 32(10):3313-3323. PubMed ID: 35792995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remission of nonalcoholic steatohepatitis after bariatric surgery: a single referral center cohort study.
    Drai C; Chierici A; Pavone G; Benamran D; Alromayan M; Alamri A; Anty R; Liddo G; Iannelli A
    Surg Obes Relat Dis; 2024 May; 20(5):482-489. PubMed ID: 38195314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional Liver Recovery After Bariatric Surgery--a Prospective Cohort Study with the LiMAx Test.
    Alizai PH; Wendl J; Roeth AA; Klink CD; Luedde T; Steinhoff I; Neumann UP; Schmeding M; Ulmer F
    Obes Surg; 2015 Nov; 25(11):2047-53. PubMed ID: 25869925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.